Brought to you by:
Intermittent Topical Wound Oxygen: ‘It needs to no longer be seen as late-stage therapy’
This advertorial is sponsored by AOTI. Two prominent vascular surgeons discuss a rising tide of evidence pointing toward benefits of adjunct use of cyclically pressurized Topical Wound Oxygen (TWO2) therapy in the treatment of vascular ulceration. The best way to…
The future of vascular surgery (and the role a hybrid OR plays in it)
This advertorial is sponsored by Siemens. Two leaders in vascular surgery preview the future of interventional imaging and consider the emergence of the hybrid operating room (OR) as a future model for success. The hybrid OR is emerging as a…
How the RevCore and VenaCore thrombectomy catheters combine to broaden treatment approach among advanced deep vein thrombosis patients previously limited to few options
This advertorial is sponsored by Inari Medical. For Joseph M. Liechty, MD, a vascular surgeon with Texas Vascular Associates in Plano, Texas, the emergence of the RevCoreTM and VenaCoreTM devices (Inari Medical) have helped broaden his treatment strategies for advanced…
Pioneering Florida limb preservation program laser-focuses on evidence-based, customized care for PAD
This advertorial is sponsored by Tampa General Hospital. As the prevalence of peripheral arterial disease (PAD) continues to climb across the U.S. and globally, a pioneering limb preservation program in south Florida is sharpening its resolve to provide cutting-edge treatment…
Incorporation of Shockwave E8 Peripheral IVL into the treatment of patients with chronic limb-threatening ischemia
This advertorial is sponsored by Shockwave Medical. Anand Prasad, MD, an 18-year veteran of vascular and endovascular medicine with a particular interest in peripheral arterial disease (PAD) in patients with chronic kidney disease (CKD), explores the deliverability of the Shockwave…
Tackling difficult acute limb ischemia cases with an endovascular-first approach using Lightning Bolt 7 computer assisted vacuum thrombectomy
This advertorial is sponsored by Penumbra, Inc. Adam Reichard, MD, discusses the use of Lightning Bolt 7® computer-assisted vacuum thrombectomy (CAVTTM) as a first-line option across a wide spectrum of challenging lower extremity acute limb ischemia (ALI) cases, including patients…
The Shockwave E8 experience: Featuring the new Shockwave peripheral IVL workhorse
This advertorial is sponsored by Shockwave Medical. Paul J. Foley III, MD, a vascular surgeon and director of the non-invasive vascular lab at Doylestown Hospital in Doylestown, Pennsylvania, and adjunct associate professor of surgery at the University of Pennsylvania in…
Pounce Thrombectomy Platform use in acute limb ischemia: Vascular surgeons weigh in
This advertorial is sponsored by Surmodics. Interventions for acute limb ischemia (ALI) represent up to 16% of the case volume for vascular surgeons and cost healthcare systems $26,000–$29,000 per patient in hospitalization costs.¹ While revascularization may be achieved via open or…
VenaCore device offers long-awaited interventional solution for challenging venous occlusions
This advertorial is sponsored by Inari Medical. Despite the recent growth in mechanical thrombectomy devices for acute deep vein thrombosis (DVT), interventional options for wall adherent venous obstruction are extremely limited. Residual venous obstruction after medical or interventional therapy for…
Laser atherectomy redefined: Breakthrough 355nm technology opens next frontier in treatment
In this supplement, sponsored by AngioDynamics: